molecular function |
| GO:0017091 | | AU-rich element binding | | Interacting selectively and non-covalently with a region of RNA containing frequent adenine and uridine bases. |
| GO:0003723 | | RNA binding | | Interacting selectively and non-covalently with an RNA molecule or a portion thereof. |
| GO:0003676 | | nucleic acid binding | | Interacting selectively and non-covalently with any nucleic acid. |
| GO:0000166 | | nucleotide binding | | Interacting selectively and non-covalently with a nucleotide, any compound consisting of a nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose or deoxyribose. |
| GO:0008143 | | poly(A) binding | | Interacting selectively and non-covalently with a sequence of adenylyl residues in an RNA molecule, such as the poly(A) tail, a sequence of adenylyl residues at the 3' end of eukaryotic mRNA. |
| GO:0005515 | | protein binding | | Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
biological process |
| GO:0006915 | | apoptotic process | | A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died. |
| GO:0008543 | | fibroblast growth factor receptor signaling pathway | | The series of molecular signals generated as a consequence of a fibroblast growth factor receptor binding to one of its physiological ligands. |
| GO:0042036 | | negative regulation of cytokine biosynthetic process | | Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of cytokines. |
| GO:0017148 | | negative regulation of translation | | Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of proteins by the translation of mRNA or circRNA. |
| GO:1904037 | | positive regulation of epithelial cell apoptotic process | | Any process that activates or increases the frequency, rate or extent of epithelial cell apoptotic process. |
| GO:1903608 | | protein localization to cytoplasmic stress granule | | A process in which a protein is transported to, or maintained in, a location within a cytoplasmic stress granule. |
| GO:0048024 | | regulation of mRNA splicing, via spliceosome | | Any process that modulates the frequency, rate or extent of mRNA splicing via a spliceosomal mechanism. |
cellular component |
| GO:0005737 | | cytoplasm | | All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| GO:0010494 | | cytoplasmic stress granule | | A dense aggregation in the cytosol composed of proteins and RNAs that appear when the cell is under stress. |
| GO:0030529 | | intracellular ribonucleoprotein complex | | An intracellular macromolecular complex containing both protein and RNA molecules. |
| GO:0097165 | | nuclear stress granule | | A dense aggregation in the nucleus composed of proteins and RNAs that appear when the cell is under stress. |
| GO:0005654 | | nucleoplasm | | That part of the nuclear content other than the chromosomes or the nucleolus. |
| GO:0005634 | | nucleus | | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |